ATLASATLAS fair value
₹541.56
Above fair value · 91% premium
Range: ₹398–₹732Fair valuePrice
Strides Pharma Science (STAR.NSE)
Strides Pharma Science share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹1,033▲ +1.80%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Strides Pharma Science in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Strides Pharma Science
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Strides Pharma Science's fair value at about ₹541.56 per share (reasonable range: ₹398.32 to ₹731.59). At ₹1,033, the stock trades 91% above it.
It is calculated with a discounted cash-flow model. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Strides Pharma Science a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹966.44 and ₹1,104; in 9 out of 10, between ₹859.18 and ₹1,241. Estimated annual volatility is 37%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹94.9B
- Market cap (USD)
- $1.0B
- P/E ratio
- 15.3
- Dividend yield
- 1.88%
- 52-week high
- ₹1,261
- 52-week low
- ₹768.65
- Revenue (12 months)
- ₹50.0B
- Operating margin
- 13.7%
- Net margin
- 12.3%
- Beta
- 0.37
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Strides Pharma Science sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks STAR.NSE has traded between ₹768.65 and ₹1,261. Today it is 18.1% below that high and 34% above its low.
On the business: net margin is 12.3%; it trades at 15.3 times earnings.
Its beta is 0.37: it tends to move less than the market.
About the company
Strides Pharma Science Ltd. is a prominent pharmaceutical company engaged in the development, manufacturing, and marketing of a wide array of pharmaceutical products.
Want to see everything about Strides Pharma Science?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Strides Pharma Science (STAR.NSE) fair value?
About ₹541.56 per share according to ATLAS (reasonable range: ₹398.32 to ₹731.59). With the stock at ₹1,033, it is 91% above it.
What is the chance STAR.NSE goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, STAR.NSE ends the month between ₹966.44 and ₹1,104.
How big is Strides Pharma Science and what is its P/E ratio?
Strides Pharma Science's market capitalization is ₹94.9B. Its price-to-earnings (P/E) ratio is 15.3: you pay ₹15.3 for each ₹1.00 of yearly earnings.
Does Strides Pharma Science pay a dividend?
Yes. STAR.NSE's current dividend yield is 1.88% at today's price (₹1,033).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer